USA TODAY: What happens to drug companies that commit federal crimes? For the nation’s No. 1 drug company, the answer is: some pain, more gain.
By ANNA WILDE MATHEWS THE WALL STREET JOURNAL EXCERPT: A new Food and Drug Administration analysis of clinical-trial data shows evidence of a link between
By LEILA ABBOUD THE WALL STREET JOURNAL Seeking to defuse criticism that pharmaceutical companies hush up negative results in clinical trials, U.S. drug maker Eli